NCT02632175CompletedPhase 3
Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Ulcerative Colitis Who Completed the Study M11-290
Source: ClinicalTrials.gov · Last updated 16 Oct 2025
Brief summary (registry, in English)
This study assesses the long-term safety and efficacy of adalimumab in pediatric subjects with ulcerative colitis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 59 (actual)
- First submitted
- 14 Dec 2015
- Start date
- 26 Nov 2015
- Primary completion date
- 8 Apr 2025
- Lead sponsor
- AbbVie
- Diseases
- Ulcerative colitis
- NCT number
- NCT02632175
- EU CT number
- 2023-504711-32-00
- EudraCT number
- 2015-001346-29
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 59
- From 26 Nov 2015 to the primary completion date, 8 Apr 2025
- 16 sites in 6 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Subject considered by the investigator, for any reason, to be an unsuitable candidate
Who the study is looking for
- \- Subject must have successfully enrolled and completed M11-290 study
Age in the registry: 4 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (16)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Vall d'Hebron /ID# 147288 Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Duplicate_The Royal Free London NHS Foundation Trust /ID# 147292 Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 147290 Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Juntendo University Hospital /ID# 147315 Coordinator of this site? Confirm its status | Bunkyo-ku | Japan | Unknown status |
| Kurume University Hospital /ID# 145710 Coordinator of this site? Confirm its status | Kurume-shi | Japan | Unknown status |
| National Center for Child Health and Development /ID# 147312 Coordinator of this site? Confirm its status | Setagaya-ku | Japan | Unknown status |
| Uniwersytecki Szpital Dzieciecy W Krakowie Coordinator of this site? Confirm its status | Cracow | Poland | Completed |
| Instytut Centrum Zdrowia Matki Polki Coordinator of this site? Confirm its status | Lodz | Poland | Completed |
| Gabinet Lekarski Bartosz Korczowski Coordinator of this site? Confirm its status | Rzeszów | Poland | Completed |
| Eb Group Sp. z o.o. Coordinator of this site? Confirm its status | Warsaw | Poland | Completed |
| Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu Coordinator of this site? Confirm its status | Wroclaw | Poland | Completed |
| Univerzitna nemocnica Martin Coordinator of this site? Confirm its status | Martin | Slovakia | Completed |
| MNGI Digestive Health, P. A. /ID# 147294 Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
| Arnold Palmer Hospital /ID# 147295 Coordinator of this site? Confirm its status | Orlando | United States | Unknown status |
| Mayo Clinic - Rochester /ID# 147304 Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
| MultiCare Institute Health System /ID# 169005 Coordinator of this site? Confirm its status | Tacoma | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.